Tarsus Pharmaceuticals, Inc.’s Post

Did you know that two-thirds of the people living with moderate-to-severe vision impairment live in East, South and Central Asia? This week Roche is bringing together over 200 ophthalmologists from across 10 markets in Asia for our APAC Ophtha Week where we will discuss how to tackle this disproportionate burden. Over the course of two days, we’ll hear from experts about current challenges facing patients, the latest innovations in treatment, and the value of meaningful partnerships to advance the field of ophthalmology. We are looking forward to the opportunity to collaborate to shape the future of vision in APAC, a future where everyone enjoys the gift of clear vision. #AROW2024 #RocheOphthalmology #RocheOphthaAPAC Ref: Chen, D., Hee, J. Y., Ho, B., Mohan, P., & Greene, W. (2019). Ophthalmology in Asia. - M-TW-00005708

Great news! We recorded the interactive session, so you can still benefit from all the insights we gained. 🎉   📽️ Watch the replay: https://bit.ly/3S3h2y3

This paper goes some way to addressing the question of “Why are doctors switching to faricimab?”

👁️🤖 Welcome to another exciting episode of 'InSight with Austin'! Join our Clinician Link.AI ™️ Ambassador, Austin Pereira, as he explores the transformative role of artificial intelligence in ophthalmology. Today, we're highlighting the groundbreaking work of Andrew Mihalache and his team at the University of Toronto, who have published studies on ChatGPT-4’s capabilities in interpreting OCT images. Their findings, featured in prestigious journals like JAMA Ophthalmology and Ophthalmology Science, provide crucial insights into AI's potential and limitations in eye care. Tune in to learn more about how AI continues to revolutionize our understanding and treatment of eye diseases. #AIinOphthalmology #MedicalInnovation #InSightWithAustin

Between 1.09 billion and 1.80 billion individuals are estimated to be affected by presbyopia globally. The need for a standardized definition, evaluation of treatments, and increased transparency in presbyopia research are key components to advancing our understanding and addressing the challenges associated with presbyopia.    True North Contract Research is excited to work alongside innovators and breakout brands towards ensuring that individuals will have more options to manage presbyopia.     Learn more about Presbyopia and current research challenges and strategies in the link below. #truenorthcontractresearch #presbyopiaresearch #presbyopia #clinicaltrials #ophthalmology  https://lnkd.in/dQ7viw49 Ophthalmology at BMJ James Wolffsohn  Leon Davies,  Amy Sheppard

In the latest episode of Science@UH, Daniel Simon,MD, and renowned ophthalmologist Jonathan Lass, MD, explore groundbreaking innovations in eye care from pioneering reading centers to advances in corneal transplants and treatments for macular degeneration. Learn more about the future of ophthalmology and how clinical research is shaping new therapeutic solutions for eye diseases at https://bit.ly/3XBfZY2

OpRegen®(RG6501) Preclinical Engraftment Results to be Presented at the 2024 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting. Read here: https://bit.ly/3Tu4voC @Retina Today #ReplaceandRestore #Retina

LAST CALL: Urgent Extension for Abstract Submission! Time is running out! We're extending the abstract submission for OSWI's 35th Congress, but the window is closing FAST. You now have until January 14, 2024, @ midnight! This is YOUR moment to make a mark on the global ophthalmology stage. Don't let this opportunity slip away – submit your abstract NOW to be part of the most thrilling event in the field! Urgency is in the air! Act NOW and be a pivotal force in shaping the future of ophthalmology! The clock is ticking loudly! #OSWI35thCongress #LastCallAbstracts #OphthalmologyInnovation

Cool stuff for eCOA and Imaging in ophthalmology research! 📣 Sign up for our July 11 webinar! Our experts Todd Rudo, Amit Vasanji, and Kelly Dumais will explore strategies to enhance patient access and precision analysis using artificial intelligence (#AI) in ophthalmology clinical trials. We’ll dive into: ▫️Vendor-agnostic, multi-modality platforms ▫️AI-enabled workflows ▫️Best practices for eCOA implementation in various trial settings ➡️ Register now and don’t miss the opportunity to learn how AI transforms ophthalmology clinical trials: https://lnkd.in/eYh52nv7 #artificialintelligence #clinicaltrials #ophthalmology

One of the ways to stay ahead in ophthalmology clinical research is by keeping up with the latest NEI findings. At True North, we leverage this knowledge to design more effective trials. What recent eye research excites you? Share below. #eyeinnovation #clinicalresearch #contractresearchorganization  National Eye Institute (NEI)